Ernexa Therapeutics ERNA
NASDAQ ERNA
$2.96 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ernexa Therapeutics (ERNA) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Ernexa Therapeutics (ERNA) reported Return on Capital Employed [ROCE] of -250.70% for Q2 2026, up 26.84 percentage points from -277.54% a year earlier and up 6.68 percentage points from the prior quarter.

Analysis

Ernexa Therapeutics (ERNA) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Ernexa Therapeutics posted Return on Capital Employed [ROCE] of -382.16%, down 317.56 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of -312.41 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -64.60% in FY2024 (+7.95 pp), -72.55% in FY2023 (+100.03 pp), -172.57% in FY2022 (+440.92 pp) and -613.49% in FY2021 (-543.73 pp).
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -478.64% in Q2 2022 and a high of -47.91% in Q4 2023.
  • Year over year, Return on Capital Employed [ROCE] gained in two of the last six quarters, with an average year-over-year change of -104.56 percentage points.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q2 2023 (a gain of 382.66 percentage points); the low point was Q2 2022 (a drop of 412.54 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -257.38% (Q1 2026), -322.42% (Q4 2025) and -209.57% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Ernexa Therapeutics 3.46 Mn 3.46 Mn - -250.70%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -250.70%
Mar 31, 2026 -257.38%
Dec 31, 2025 -322.42%
Sep 30, 2025 -209.57%
Jun 30, 2025 -277.54%
Dec 31, 2024 -440.84%
Sep 30, 2024 -109.28%
Jun 30, 2024 -57.15%
Mar 31, 2024 -51.90%
Dec 31, 2023 -47.91%
Sep 30, 2023 -50.30%
Jun 30, 2023 -95.98%
Mar 31, 2023 -242.61%
Dec 31, 2022 -238.14%
Sep 30, 2022 -224.98%
Jun 30, 2022 -478.64%
Mar 31, 2022 -373.26%
Dec 31, 2021 -357.84%
Sep 30, 2021 -226.18%
Jun 30, 2021 -66.10%
API Access

Ernexa Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ERNA&period=max&api_key=YOUR_API_KEY